#ITI#A holistic approach to fragile X syndrome integrated guidance for person-centred care#FTI#
#IRE#Background: The Fragile X community has expressed a desire for centralised, national guidelines in the form of integrated guidance for Fragile X Syndrome (FXS). Methods: This article draws on existing literature reviews, primary research and clinical trials on FXS, a Fragile X Society conference workshop and first-hand experience of clinicians who have worked with those living with FXS over many years. Results: The article scopes proposed integrated guidance over the life course, including appendices of symptoms, comorbidities and referral options for FXS and Fragile X Premutation Associated Conditions. Conclusion: Integrated guidance would provide an authoritative source for doctors, health professionals, therapists, care workers, social workers, educators, employers, families and those living with FXS, so that a holistic, person-centred approach can be taken across the United Kingdom to garner the best outcomes for those with FXS#FRE#
#IPC#autism; fragile X syndrome; FXPAC (fragile X premutation associated conditions); integrated guidance; intellectual disability; newborn screening#FPC#
#IRF#Allen E.G., Charen K., Hipp H.S., Shubeck L., Amin A., He W., Hunter J.E., Sherman S.L., Clustering of comorbid conditions among women who carry an FMR1 premutation, Genetics in Medicine, 22, pp. 758-766, (2020); 
Allen E.G., Glicksman A., Tortora N., Charen K., He W., Amin A., Hipp H., Shubeck L., Nolin S.L., Sherman S.L., FXPOI: Pattern of AGG interruptions does not show an association with age at amenorrhea among women with a premutation, Frontiers in Genetics, 9, (2018); 
Arvio M., Fragile-X syndrome–a 20-year follow-up study of male patients, Clinical Genetics, 89, 1, pp. 55-59, (2016); 
Bailey D.B., Raspa M., Holiday D., Bishop E., Olmsted M., Functional skills of individuals with fragile x syndrome: A lifespan cross-sectional analysis, American Journal on Intellectual and Developmental Disabilities, 114, 4, pp. 289-303, (2009); 
Bailey D.B., Raspa M., Bishop E., Holiday D., No change in the age of diagnosis for fragile x syndrome: Findings from a national parent survey, Pediatrics, 124, pp. 527-533, (2009); 
Bartholomay K., Lee C., Bruno J., Lightbody A., Reiss A., Closing the gender gap in fragile X syndrome: Review of females with fragile X syndrome and preliminary research findings, Brain Sciences, 9, 1, (2019); 
Berry-Kravis E., Filipink R.A., Frye R.E., Golla S., Morris S.M., Andrews H., Choo T.-H., Kaufmann W., Seizures in fragile X syndrome: Associations and longitudinal analysis of a large clinic-based cohort, Frontiers in Pediatrics, 9, pp. 2296-2360, (2021); 
Berry-Kravis E., Hagerman R., Budimirovic D., Erickson C., Heussler H., Tartaglia N., Cohen J., Tassone F., Dobbins T., Merikle E., Sebree T., Tich N., Palumbo J.M., O'Quinn S., A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX), Journal of Neurodevelopmental Disorders, 14, 1, (2022); 
Biancalana V., Glaeser D., McQuaid S., Steinbach P., EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders, European Journal of Human Genetics, 23, pp. 417-425, (2015); 
Boardman F.K., Attitudes toward population screening among people living with fragile X syndrome in the UK: ‘I wouldn't wish him away, I'd just wish his fragile X syndrome away’, Journal of Genetic Counseling, 30, 1, pp. 85-97, (2021); 
Budimirovic D.B., Protic D.D., Delahunty C.M., Andrews H.F., Choo T.H., Xu Q., Berry-Kravis E., Kaufmann W.E., Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort, American Journal of Medical Genetics. Part A, 188, 4, pp. 1029-1039, (2022); 
Transitions, (2022); 
Percorso Diagnostico, Terapeutico e Assistenziale (PDTA) relativo a: Sindrome Del Cromosoma X Fragile, (2018); 
Be Well Checklist, (2023); 
Clark G.F., Kingsley K.L., Occupational therapy practice guidelines for early childhood: Birth–5 years, The American Journal of Occupational Therapy, 74, 3, pp. 1-42, (2020); 
Cordeiro L., Ballinger E., Hagerman R., Hessl D., Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: Prevalence and characterization, Journal of Neurodevelopmental Disorders, 3, pp. 57-67, (2011); 
Crawford H., Abbeduto L., Hall S.S., Hardiman R., Hessl D., Roberts J.E., Scerif G., Stanfield A.C., Turk J., Oliver C., Fragile X syndrome: An overview of cause, characteristics, assessment and management, Paediatrics and Child Health, 30, pp. 400-403, (2020); 
Crawford H., Karakatsani E., Singla G., Oliver C., The persistence of self-injurious and aggressive behavior in males with fragile X syndrome over 8 years: A longitudinal study of prevalence and predictive risk markers, Journal of Autism and Developmental Disorders, 49, pp. 2913-2922, (2019); 
Crawford H., Moss J., Groves L., Dowlen R., Nelson L., Reid D., Oliver C., A behavioural assessment of social anxiety and social motivation in fragile X, Cornelia de Lange and Rubinstein-Taybi syndromes, Journal of Autism and Developmental Disorders, 50, 1, pp. 127-144, (2020); 
Crawford H., Stanfield A., Johnson K., Developing fragile X guidelines [fragile X society conference consultation discussion, Birmingham, UK], (2022); 
What is POI, (2023); 
Kwaliteitsstandaard fragiele X syndroom, (2023); 
de Sante H.A., Syndrome de l'X Fragile, Guide Maladie Chronique, (2021); 
Dembo R.S., Hong J., DaWalt L.S., Berry-Kravis E.M., Mailick M.R., Health effects of sleep quality in premutation carrier mothers of individuals with fragile X syndrome, American Journal on Intellectual and Developmental Disabilities, 128, 3, pp. 254-268, (2023); 
Doherty B.R., Longhi E., Cole V., Kamiloff-Smith A., Cornish K., Scerif G., Disentangling autism spectrum and attention-deficit/hyperactivity symptoms over development in fragile x syndrome, Research in Developmental Disabilities, 104, (2020); 
Doherty B.R., Scerif G., Genetic syndromes and developmental risk for autism Spectrum and attention deficit hyperactivity disorders: Insights from fragile X syndrome, Child Development Perspectives, 11, pp. 161-166, (2017); 
Dunphy R., Fragile X Syndrome, Royal College of General Practitioners, 13, 12, pp. 712-716, (2020); 
Eley S., McKechanie A.G., Stanfield A.C., Community views on medication use in fragile X syndrome, PREPRINT (Version 1) available at Research Square, (2022); 
Fielding-Gebhardt H., Warren S.F., Brady N.C., Developmental trajectory of communication repair in children with fragile X syndrome, Autism & Developmental Language Impairments, 5, (2020); 
Finestack L.H., Richmond E.K., Abbeduto L., Language development in individuals with fragile X syndrome, Topics in Language Disorders, 29, pp. 133-148, (2009); 
Forster-Gibson C., Berg J.M., Health watch Table - fragile X syndrome, (2011); 
What is fragile X?, (2023); 
What is fragile X syndrome, (2023); 
Fu Y.-H., Kuhl D.P.A., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., Verkert A.J.M.H., Holden J.J.A., Fenwick R.G., Warren S.T., Oostra B.A., Nelson D.L., Caskey C.T., Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox, Cell, 67, pp. 1047-1058, (1991); 
Care Coordination Report, (2023); 
Kaleb's story: Fragile X syndrome, (2023); 
Guy J., Ng-Cordell E., Doherty B.R., Duta M., Scerif G., Understanding attention, memory and social biases in fragile X syndrome: Going below the surface with a multi-method approach, Research in Developmental Disabilities, 104, (2020); 
Hagerman R.J., Berry-Kravis E., Kaufmann W.E., Ono M.Y., Tartaglia N., Lachiewicz A., Kronk R., Delahunty C., Hessl D., Visootsak J., Picker J., Gane L., Tranfaglia M., Advances in the treatment of fragile X syndrome, Pediatrics, 123, pp. 378-390, (2009); 
Hagerman R.J., Protic D., Rajaratnam A., Salcedo-Arellano M.J., Aydin E.Y., Schneider A., Fragile X-associated neuropsychiatric disorders (FXAND), Frontiers in Psychiatry, 13, 9, (2018); 
Hardiman R.L., McGill P., The topographies and operant functions of challenging behaviours in fragile X syndrome: A systematic review and analysis of existing data, Journal of Intellectual & Developmental Disability, 42, 2, pp. 109-203, (2017); 
Hess L., Fitzpatrick S., Nguyen D., Chen Y., Gaul K., Schneider A., Chitwood K., Eldeeb M., Polussa J., Hessl D., Rivera S., Hagerman R., A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome, Journal of Developmental & Behavioral Pediatrics, 37, 8, pp. 619-628, (2016); 
Conditions approved for pre-implantation genetic testing for monogenic disorders (PGT-M), (2023); 
Hoghton M., A Step by Step Guide for GP Practices: Annual Health Checks for People with a Learning Disability, (2010); 
Huddleston L.B., Visootsak J., Sherman S.L., Cognitive aspects of fragile X syndrome, Wiley Interdisciplinary Reviews: Cognitive Science, 5, pp. 501-508, (2014); 
Hunter J., Rivero-Arias O., Angelov A., Kim E., Fotheringham I., Leal J., Epidemiology of fragile X syndrome: A systematic review and meta-analysis, American Journal of Medical Genetics Part A, 164A, pp. 1648-1658, (2014); 
Hunter J.E., Berry-Kravis E., Hipp H., Todd P.K., FMR1 Disorders, GeneReviews®, 1993-2023, (2019); 
Iriarte-Redin C., Soriano-Ferrer M., Hidalgo-Ales B., Impact of fragile X syndrome on their families, Psicología Educativa, 27, pp. 93-99, (2020); 
Jalnapurkar I., Cochran D.M., Frazier J.A., New therapeutic options for fragile X syndrome, Current Treatment Options in Neurology, 21, 3, (2019); 
Johnson K., Herring J., Richstein J., Fragile X premutation associated conditions (FXPAC), Frontiers in Pediatrics, 8, (2020); 
Kaufmann W.E., Kidd S.A., Andrews H.F., Budimirovic D.B., Esler A., Haas-Givler B., Stackhouse T., Riley C., Peacock G., Sherman S.L., Brown W.T., Berry-Kravis E., Autism spectrum disorder in fragile X syndrome: Cooccurring conditions and current treatment, Pediatrics, 139, pp. 194-206, (2017); 
Knott L., Fragile X Syndrome, (2021); 
Lachiewicz A.M., Stackhouse T.M., Burgess K., Burgess D., Andrews H.F., Choo T.H., Kaufmann W.E., Kidd S.A., Sensory symptoms and signs of hyperarousal in individuals with fragile X syndrome: Findings from the FORWARD registry and database multisite study, Journal of Autism and Developmental Disorders, (2023); 
Landa R.J., Efficacy of early interventions for infants and young children with, and at risk for, autism spectrum disorders, International Review of Psychiatry (Abingdon, England), 30, 1, pp. 25-39, (2018); 
Lee S., Taylor J.L., Redmond C., Hadd A.G., Kemppainen J.A., Haynes B.C., Shone S., Bailey D.B., Latham G.J., Validation of fragile X screening in the newborn population using a fit-for-purpose FMR1 PCR assay system, The Journal of Molecular Diagnostics, 22, pp. 346-354, (2020); 
Leehey M.A., Hall D.A., Liu Y., Hagerman R.J., Clinical neurological phenotype of FXTAS, FXTAS, FXPOI, and other premutation disorders, (2016); 
Lieb-Lundell C.C.E., Three faces of fragile X, Physical Therapy, 96, 11, pp. 1782-1790, (2016); 
Lightbody A.A., Bartholomay K.L., Jordan T.L., Lee C.H., Miller J.G., Reiss A.L., Anxiety, depression, and social skills in girls with fragile X syndrome: Understanding the cycle to improve outcomes, Journal of Developmental and Behavioral Pediatrics, 43, pp. 565-572, (2022); 
Lozano R., Azarang A., Wilaisakditipakorn T., Hagerman R.J., Fragile X syndrome: A review of clinical management, Intractable & Rare Diseases Research, 5, 3, pp. 145-157, (2016); 
McKechanie A., Barnicoat A., Trender-Gerhard I., Allison M., Stanfield A., Fragile X-associated conditions: Implications for the whole family, British Journal of General Practice, 69, pp. 460-461, (2019); 
McKechanie A.G., Lawrie S.M., Stanfield A.C., The never-changing face of fragile X?, The Lancet: Psychiatry, 7, (2020); 
Movaghar A., Page D., Brilliant M., Baker M.W., Greenberg J., Hong J., Dawalt L.S., Saha K., Kuusisto F., Stewart R., Berry-Kravis E., Mailick M.R., Data-driven phenotype discovery of FMR1 premutation carriers in a population-based sample, Science Advances, 5, (2019); 
Movaghar A., Page D., Brilliant M., Mailick M., Prevalence of underdiagnosed fragile X syndrome in 2 health systems, JAMA Network Open, 4, (2021); 
Primary health care of people with a learning disability, (2023); 
Fragile X 101, (2023); 
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges, (2015); 
Autism spectrum disorder in under 19 s: recognition, referral and diagnosis, (2017); 
Learning disabilities and behaviour that challenges: service design and delivery, (2018); 
Care and support of people growing older with learning disabilities, (2018); 
Attention deficit hyperactivity disorder: diagnosis and management, (2019); 
Autism spectrum disorder in adults: diagnosis and management, (2021); 
Autism spectrum disorder in under 19s: support and management, (2021); 
Prader-Willi syndrome, (2021); 
Annual health checks: Learning disabilities, (2022); 
National genomic test directory, (2023); 
Annual Health Check, (2023); 
Ouyang L., Grosse S.D., Riley C., Bolen J., Bishop E., Raspa M., Bailey D.B., A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability, Research in Developmental Disabilities, 35, pp. 1518-1527, (2014); 
Potter S.N., Harvey D.J., Sterling A., Abbeduto L., Fragile X syndrome, mental health challenges, parenting stress, and features of the couple relationship in parents of children with fragile X syndrome, Frontiers in Psychiatry, 13, (2022); 
Protic D.D., Aishworiya R., Salcedo-Arellano M.J., Tang S.J., Milisavljevic J., Mitrovic F., Hagerman R.J., Budimirovic D.B., Fragile X syndrome: From molecular aspect to clinical treatment, International Journal of Molecular Sciences, 23, (2022); 
Rivera S.M., Menon V., White C.D., Glaser B., Reiss A.L., Functional brain activation during arithmetic processing in females with fragile X syndrome is related to FMR1 protein expression, Human Brain Mapping, 16, pp. 206-218, (2002); 
Roberts J., Crawford H., Hogan A.L., Fairchild A., Tonnsen B., Brewe A., O'Connor S., Roberts D.A., Abbeduto L., Social avoidance emerges in infancy and persists into adulthood in fragile X syndrome, Journal of Autism and Developmental Disorders, 49, pp. 3753-3766, (2019); 
Roberts J.E., Crawford H., Will E.A., Hogan A.L., McQuillin S., Tonnsen B.L., O'Connor S., Roberts D.A., Brewe A.M., Infant social avoidance predicts autism but not anxiety in fragile X syndrome, Frontiers in Psychiatry, 10, 199, (2019); 
Sachdeva A., Jain P., Gunasekaran V., Mahay S.B., Mukherjee S., Hagerman R., Shankar S., Kapoor S., Kedia S.N., Consensus Statement of the Indian academy of pediatrics on diagnosis and Management of Fragile X Syndrome in India, Indian Pediatrics, 56, 3, pp. 221-228, (2019); 
Sauna-aho O., Bjelogrlic-Laakso N., Rautava P., Arvio M., Ageing and cognition in men with fragile X syndrome, Journal of Applied Research in Intellectual Disabilities, 33, pp. 1113-1118, (2020); 
Schneider A., Ligsay A., Hagerman R.J., Fragile X syndrome: An aging perspective, Developmental Disabilities Research Reviews, 18, 1, pp. 68-74, (2013); 
The National Health Service (Scotland) act 1978: The Annual Health Checks for People with Learning Disabilities (Scotland) Directions 2022, (2022); 
Smith K., Chandler K., Hindley D., Ramsden S.C., Fragile X syndrome testing in the north west, Archives of Disease in Childhood, 98, (2013); 
Tassanakijpanich N., Cohen J., Cohen R., Srivatsa U.N., Hagerman R.J., Cardiovascular problems in the fragile X premutation, Frontiers in Genetics, 11, (2020); 
Tassone F., Protic D., Allen E., Archibald A., Baud A., Brown W., Budimirovic D., Cohen J., Dufour B., Eiges R., Elvassore N., Gabis L., Grudzien S., Hall D., Hessl D., Hogan A., Hunter J., Jin P., Jiraanont P., Hagerman R., Insight and recommendations for fragile X-premutation-associated conditions from the fifth international conference on FMR1 premutation, Cell, 12, (2023); 
Tumiene B., Peters H., Melegh B., Peterlin B., Utkus A., Fatkulina N., Pfliegler G., Graessner H., Hermanns S., Scarpa M., Blay J.Y., Ashton S., McKay L., Baynam G., Rare disease education in Europe and beyond: Time to act, Orphanet Journal of Rare Diseases, 17, (2022); 
Utari A., Adams E., Berry-Kravis E., Chavez A., Scaggs F., Ngotran L., Boyd A., Hessl D., Gane L.W., Tassone F., Tartaglia N., Leehey M.A., Hagerman R.J., Aging in fragile X syndrome, Journal of Neurodevelopmental Disorders, 2, pp. 70-76, (2010); 
Informatie voor de Huisarts over Fragiele X Syndroom, (2014); 
Huisartsenbrochure Fragiele X-dragerschapgerelateerde aandoeningen: FXTAS en FXPOI, (2015); 
Wheeler A.C., Gwaltney A., Raspa M., Okoniewski K.C., Berry-Kravis E., Botteron K.N., Budimirovic D., Hazlett H.C., Hessl D., Losh M., Martin G.E., Rivera S.M., Roberts J.E., Bailey D.B., Emergence of developmental delay in infants and toddlers with an FMR1 mutation, Pediatrics, 147, 5, (2021); 
Winarni T.I., Schneider A., Borodyanskara M., Hagerman R.J., Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome, Case Reports in Genetics, 2012, (2012); 
Wirojanan J., Jacquemont S., Diaz R., Bacalman S., Anders T.F., Hagerman R.J., Goodlin-Jones B.L., The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome, Journal of Clinical Sleep Medicine, 5, pp. 145-150, (2009); 
LD55 Fragile X Chromosome. ICD-11, (2023); 
Fragile X Syndrome, (2023)#FRF#
